PT Diagnos Laboratorium Utama Tbk
DGNS.JK
Get informed when a big investor buys or sells
+ FollowMarket Cap$412.5B
Close$
Share Statistics
| Market cap | $412.50 Billion |
|---|---|
| Enterprise Value | $468.82 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.35 |
| Beta | 0.38 |
| Outstanding Shares | 1,494,392,000 |
Return
| Return on Equity | 0.89% |
|---|---|
| Return on Assets | 0.60% |
| Return on Invested Capital | 1.82% |
Valuation & Multiples
| P/E Ratio | 161.29 |
|---|---|
| PEG | 49.95 |
| Price to Sales | 2.44 |
| Price to Book Ratio | 1.87 |
| Enterprise Value to Revenue | 2.66 |
| Enterprise Value to EBIT | 81.85 |
| Enterprise Value to Net Income | 229 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.32 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PT Diagnos Laboratorium Utama Tbk
87 employees
CEO: Fergus Richard PT Diagnos Laboratorium Utama Tbk delivers comprehensive medical laboratory services across Indonesia. The company offers a wide range of diagnostic tests, including clinical pathology services covering hematology, hemostasis, clinical c...